C4 Therapeutics (CCCC) Other Accumulated Expenses (2019 - 2022)

C4 Therapeutics has reported Other Accumulated Expenses for 4 years, with the latest figure at $309000.0 in Q1 2022.

• For the quarter ending Q1 2022, Other Accumulated Expenses fell 65.16% year-over-year to $309000.0; the trailing twelve-month figure through Mar 2022 stood at $309000.0 (down 65.16% YoY), and the FY2021 full-year result was $413000.0, down 11.94% from the prior year.
• Other Accumulated Expenses for Q1 2022 stood at $309000.0, down from $413000.0 in the prior quarter.
• The five-year high for Other Accumulated Expenses was $887000.0 in Q1 2021, with the low at $164000.0 in Q3 2020.
• Average Other Accumulated Expenses over 4 years is $370750.0, with a median of $294500.0 recorded in 2019.
• Year-over-year, Other Accumulated Expenses surged 67.5% in 2020 and plunged 65.16% in 2022.
• Tracing CCCC's Other Accumulated Expenses over 4 years: stood at $280000.0 in 2019, then surged by 67.5% to $469000.0 in 2020, then slipped by 11.94% to $413000.0 in 2021, then retreated by 25.18% to $309000.0 in 2022.
• The last three Other Accumulated Expenses figures came in at $309000.0 (Q1 2022), $413000.0 (Q4 2021), and $201000.0 (Q3 2021), per Business Quant data.

Peer Comparison